A bibliometric analysis of COVID-19 research in Africa.


Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
05 2021
Historique:
received: 17 03 2021
revised: 19 04 2021
accepted: 20 04 2021
entrez: 11 5 2021
pubmed: 12 5 2021
medline: 14 5 2021
Statut: ppublish

Résumé

The COVID-19 pandemic has led to an unprecedented global research effort to build a body of knowledge that can inform mitigation strategies. We carried out a bibliometric analysis to describe the COVID-19 research output in Africa in terms of setting, study design, research themes and author affiliation. We searched for articles published between 1 December 2019 and 3 January 2021 from various databases including PubMed, African Journals Online, medRxiv, Collabovid, the WHO global research database and Google. All article types and study design were included. A total of 1296 articles were retrieved. 46.6% were primary research articles, 48.6% were editorial-type articles while 4.6% were secondary research articles. 20.3% articles used the entire continent of Africa as their study setting while South Africa (15.4%) was the most common country-focused setting. The most common research topics include 'country preparedness and response' (24.9%) and 'the direct and indirect health impacts of the pandemic' (21.6%). However, only 1.0% of articles focus on therapeutics and vaccines. 90.3% of the articles had at least one African researcher as author, 78.5% had an African researcher as first author, while 63.5% had an African researcher as last author. The University of Cape Town leads with the greatest number of first and last authors. 13% of the articles were published in medRxiv and of the studies that declared funding, the Wellcome Trust was the top funding body. This study highlights Africa's COVID-19 research and the continent's existing capacity to carry out research that addresses local problems. However, more studies focused on vaccines and therapeutics are needed to inform local development. In addition, the uneven distribution of research productivity among African countries emphasises the need for increased investment where needed.

Sections du résumé

BACKGROUND
The COVID-19 pandemic has led to an unprecedented global research effort to build a body of knowledge that can inform mitigation strategies. We carried out a bibliometric analysis to describe the COVID-19 research output in Africa in terms of setting, study design, research themes and author affiliation.
METHODS
We searched for articles published between 1 December 2019 and 3 January 2021 from various databases including PubMed, African Journals Online, medRxiv, Collabovid, the WHO global research database and Google. All article types and study design were included.
RESULTS
A total of 1296 articles were retrieved. 46.6% were primary research articles, 48.6% were editorial-type articles while 4.6% were secondary research articles. 20.3% articles used the entire continent of Africa as their study setting while South Africa (15.4%) was the most common country-focused setting. The most common research topics include 'country preparedness and response' (24.9%) and 'the direct and indirect health impacts of the pandemic' (21.6%). However, only 1.0% of articles focus on therapeutics and vaccines. 90.3% of the articles had at least one African researcher as author, 78.5% had an African researcher as first author, while 63.5% had an African researcher as last author. The University of Cape Town leads with the greatest number of first and last authors. 13% of the articles were published in medRxiv and of the studies that declared funding, the Wellcome Trust was the top funding body.
CONCLUSIONS
This study highlights Africa's COVID-19 research and the continent's existing capacity to carry out research that addresses local problems. However, more studies focused on vaccines and therapeutics are needed to inform local development. In addition, the uneven distribution of research productivity among African countries emphasises the need for increased investment where needed.

Identifiants

pubmed: 33972261
pii: bmjgh-2021-005690
doi: 10.1136/bmjgh-2021-005690
pmc: PMC8111873
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 092654
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Glob Food Sec. 2020 Sep;26:100410
pubmed: 32834955
BMJ Glob Health. 2021 Mar;6(3):
pubmed: 33648979
J Clin Orthop Trauma. 2020 May;11(Suppl 3):S304-S306
pubmed: 32405191
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Trop Med Health. 2020 May 13;48:32
pubmed: 32425653
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
BMJ Glob Health. 2021 Mar;6(3):
pubmed: 33648978
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33028699
BMJ. 2005 Oct 1;331(7519):742
pubmed: 16195291
BMJ Glob Health. 2019 Mar 4;4(2):e001047
pubmed: 30899571
Med J Islam Repub Iran. 2020 May 23;34:51
pubmed: 32934940
J Clin Epidemiol. 2020 Sep;125:170-178
pubmed: 32526460
PLoS Biol. 2021 Apr 2;19(4):e3000959
pubmed: 33798194
PLoS One. 2011;6(12):e28759
pubmed: 22194905
BMC Infect Dis. 2020 Aug 1;20(1):561
pubmed: 32738881
J Clin Virol. 2020 Jun;127:104371
pubmed: 32315817
Int J Epidemiol. 2012 Dec;41(6):1829-46
pubmed: 23283719
BMJ Open. 2015 Mar 13;5(3):e006340
pubmed: 25770227
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1809-1814
pubmed: 32956925
BMJ Glob Health. 2019 Oct 18;4(5):e001855
pubmed: 31750001
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Infect Dis Poverty. 2020 Mar 17;9(1):29
pubmed: 32183901

Auteurs

Fatuma Hassan Guleid (FH)

Policy Engagement & Knowledge Translation Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.

Robinson Oyando (R)

Health Economics Research Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.

Evelyn Kabia (E)

Health Economics Research Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.

Audrey Mumbi (A)

Health Economics Research Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.

Samuel Akech (S)

Health Services Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.

Edwine Barasa (E)

Health Economics Research Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya EBarasa@kemri-wellcome.org.
Center for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH